These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25362039)
1. Relation between uric acid and Alzheimer's disease in elderly Jordanians. Al-khateeb E; Althaher A; Al-khateeb M; Al-Musawi H; Azzouqah O; Al-Shweiki S; Shafagoj Y J Alzheimers Dis; 2015; 44(3):859-65. PubMed ID: 25362039 [TBL] [Abstract][Full Text] [Related]
2. Decreased plasma antioxidants in patients with Alzheimer's disease. Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775 [TBL] [Abstract][Full Text] [Related]
3. Relation between copper, lipid profile, and cognition in elderly Jordanians. Al-khateeb E; Al-zayadneh E; Al-dalahmah O; Alawadi Z; khatib F; Naffa R; Shafagoj Y J Alzheimers Dis; 2014; 41(1):203-11. PubMed ID: 24583404 [TBL] [Abstract][Full Text] [Related]
6. Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease. Can M; Varlibas F; Guven B; Akhan O; Yuksel GA Eur Neurol; 2013; 69(6):377-80. PubMed ID: 23751563 [TBL] [Abstract][Full Text] [Related]
7. Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis. Chen X; Guo X; Huang R; Chen Y; Zheng Z; Shang H PLoS One; 2014; 9(4):e94084. PubMed ID: 24714617 [TBL] [Abstract][Full Text] [Related]
8. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease. Teunissen CE; van der Flier WM; Scheltens P; Duits A; Wijnstok N; Nijpels G; Dekker JM; Blankenstein RM; Heijboer AC J Alzheimers Dis; 2015; 44(3):809-13. PubMed ID: 25352450 [TBL] [Abstract][Full Text] [Related]
9. Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years. Wu Y; Zhang D; Pang Z; Jiang W; Wang S; Tan Q Geriatr Gerontol Int; 2013 Jul; 13(3):672-7. PubMed ID: 23170844 [TBL] [Abstract][Full Text] [Related]
10. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
11. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study. Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573 [TBL] [Abstract][Full Text] [Related]
12. Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer's disease. Cankurtaran M; Yesil Y; Kuyumcu ME; Oztürk ZA; Yavuz BB; Halil M; Ulger Z; Cankurtaran ES; Arıoğul S J Alzheimers Dis; 2013; 33(4):1051-8. PubMed ID: 23109556 [TBL] [Abstract][Full Text] [Related]
13. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084 [TBL] [Abstract][Full Text] [Related]
14. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease. Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966 [TBL] [Abstract][Full Text] [Related]
15. Assessment of serum uric acid as risk factor for tauopathies. Schirinzi T; Di Lazzaro G; Colona VL; Imbriani P; Alwardat M; Sancesario GM; Martorana A; Pisani A J Neural Transm (Vienna); 2017 Sep; 124(9):1105-1108. PubMed ID: 28620833 [TBL] [Abstract][Full Text] [Related]
16. Uric acid and cognition in Parkinson's disease: a follow-up study. Annanmaki T; Pohja M; Parviainen T; Hakkinen P; Murros K Parkinsonism Relat Disord; 2011 Jun; 17(5):333-7. PubMed ID: 21320793 [TBL] [Abstract][Full Text] [Related]
17. Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia. Liu H; Reynolds GP; Wei X J Alzheimers Dis; 2020; 73(3):1125-1131. PubMed ID: 31884488 [TBL] [Abstract][Full Text] [Related]